Research Services Office 2500 University Drive NW 3rd Floor MacKimmie Library Tower Calgary, AB, Canada T2N 1N4 nihgrant@ucalgary.ca National Institutes of Health (NIH) Lead site Application Checklist General Information Objectives NIH funds foreign institutions for projects having specific relevance to the objectives of the Institutes and Centers (IC) and has the potential for significantly advancing the health sciences in the United States. This checklist applies to NIH grants in which University of Calgary is the submitting institution, applying to receive funds directly from NIH through a Notice of Award. Eligibility Read the Eligibility Section of the Funding Opportunity Announcement (FOA) to ensure non-U.S. entities are eligible to apply. Principle investigators must be registered in eRA Commons. Please contact Research Services to register. Common Types of NIH Applications: R01 – Research Grant Used to support a discrete, specified research project NIH’s most commonly used grant program Budget – costs appropriate for the project, typically <$500,000 per year Generally awarded for 3-5 years R21 – Exploratory Research Grant New, exploratory & development projects, supports early stages of project Limited to up to two years of funding Budget for direct costs for the two year project period up to $275,000 U01 – Research Project Cooperative Agreement Supports discrete, specified projects to be performed by investigator(s) in an area representing specific interests and competencies No specific dollar amount – amount and years specified in FOA Application Deadline to Research Services Office: The internal deadline for a detailed administrative review and institutional approval is 2 weeks prior to the agency deadline. The 2 week deadline is required for lead application with consortium applicants. This extended deadline is to ensure there is sufficient time to request and receive all required documents from the sub-sites (signed facepage, letter of intent to collaborate, budgets, budget justifications, bio sketches). The detailed administrative review includes a detailed review of the application, checking for eligibility and UofC commitments and risk, compliance with program guidelines, completeness of application, and the opportunity for feedback to improve the application. Page 2 of 10 For lead application without consortium components, the final deadline for a basic review is 4 business days (noon) prior to the agency deadline. Please note, these 2 additional days are required to ensure an error-free submission of the application. Applications will not be accepted after this time. Please check with your Department and Associate Dean Research office for timelines and processes to obtain signatures prior to submitting to Research Services. The basic administrative review involves a minimal check of the application for eligibility and any UofC commitment or risk. Additional Information: Unsolicited Applications (Parent Announcements) Funding Opportunities and Notices Grant Application Basics Application Guide Grants.gov eRA Commons Peer Review Process Page 3 of 10 Application Checklist To apply, submit a completed electronic application, downloaded from the Funding Opportunity Announcement (FOA) webpage and a complete, signed Research Funding Application Approvals. Click here for full instructions. Application Overview Grant Application Package SF 424 (R&R) PHS 398 Research Plan PHS 398 Cover Page Supplement Research & Related Senior/Key Person Profile (Expanded) Research & Related Other Project Information Project/Performance Site Location(s) Research & Related Budget Attachments Specific Aims Research Strategy Resource Sharing Plan Biographical Sketch for Senior/Key Personnel Foreign Justification Project Summary Project Narrative Facilities and Other Resources Equipment Budget Justification Formatting Attachments Font: Use Arial, Helvetica, Palatino Linotype, or Georgia typeface in black font color. After text attachments are converted to PDF, font size in each final PDF document must be at least 11 points. Margins: The final PDF document should have at least one-half inch margins (top, bottom, left, and right) for all pages. No information should appear in the margins, including the PI’s name and page numbers. A. Create an Application 1. Follow the “Apply for Grant Electronically” button Funding Opportunity Announcement (FOA). Click “Proceed to Grants.gov to Download Application.” Click “Download.” Either submit email, or check that you do not wish to provide your email. Click “Download Application Package.” 2. Check the Research & Related Budget. Click “Add Period” on budget until all budget periods are included. 3. Check all other optional forms that apply to your application to add them. B. Complete the Application 1. Include title under application filing name. Page 4 of 10 SF 424 (R&R) 1. Type of submission Pre-application – do not use Pre-application unless specifically noted in FOA. Application – use for first submission attempt Changed/Corrected Application – use Changed/Corrected when correcting eRA errors/warnings. If submitting a Changed/Corrected, include 3.c. the Previous Grants.gov Tracking ID. 5. Applicant Information Legal Name: Governors of the University of Calgary Address: 2500 University Drive NW, Calgary, Alberta, CAN: CANADA T2N 1N4 Person to be contacted: Anna LeMarquand Address: 2500 University Drive NW, Calgary, Alberta, CAN: CANADA T2N 1N4 Phone number: 403-210-9815 Fax number: 403-289-0693 Email: nihgrant@ucalgary.ca 6. University of Calgary Employer Identification: 23-7067592 7. Type of Applicant: W: Non-domestic (non-US) Entity 8. Type of Application: See Application Guide for definitions 11. Title: NIH only saves first 81 characters of Project Title. If revision, provide exact title (including punctuation and spacing) as provided for awarded grant. 12. Proposed Project: Ensure that dates match those given in the budget 13. Congressional District: 00-000 15. Estimated Project Funding: give total requested funds, including direct and indirect costs 16. Is Application subject to review?: Check NO, Program is not covered by E.O. 12372 19. Authorized Representative Lorna Very, Director, Grants, Awards and Ethics 2500 University Drive NW, Calgary, Alberta, CAN: CANADA T2N 1N4 Phone number: 403-220-4121 Fax number: 403-289-0693 Email: very@ucalgary.ca 21. Cover Letter Attachment: Required for re-submissions, recommended for new applications to request application be directed to a specific institute and study section PHS 398 Research Plan 1. Introduction: Provide for Resubmission or Revision only. Maximum of 1 page for revision, as well as for resubmissions, unless indicated otherwise in the FOA. Resubmission: Summarizes the substantial additions, deletions, and changes to the application. Resubmission: Response to issues and criticisms. Revision: Describe nature of the supplement and how it will influence the specific aims, research designs, and methods of the current grant. 2. Specific Aims: Required unless otherwise specified in FOA. Limited to 1 page. State the goals of the proposed research, the expected outcomes, the impact of the research field(s) involved and the specific objectives. 3. Research Strategy: 12 pages for R01 and U01, 6 pages for R21, or following FOA instructions. Start each section with the appropriate section heading: Significance, Innovation, Approach. Significance: The importance of the problem, how the proposed project will improve knowledge, capacity and/or practice, and how the field will be changed if proposed aims are achieved. Innovation: How the application challenges and shifts current research or practice, describe any novel concepts, methods or instrumentation, and explain any improvements or new applications. Approach: Describe overall strategy, methodology, and analyses, address Research Sharing Plan (unless submitting as separate attachment), discuss problems, strategies and benchmarks for aims, and Page 5 of 10 procedures, situations or materials that may be hazardous. If there are multiple Specific Aims, Significance, Innovation and Approach may be addressed for each Specific Aim. Include information on Preliminary Studies (not required for R21 applications). Renewal/Resubmission: provide a Progress Report with beginning and end dates. If providing a Progress Report, attach a Progress Report Publication List. 4. Human Subjects section - If you answered “yes” to the question “are human subjects involved?” On the R&R Other Project Information Form, you must provide a) Protection of Human Subjects, b) Inclusion of Women and Minorities and c) Inclusion of Children attachments. If you answered “no” to the question “are human subjects involved?” but your research involves human specimens and/or data, you must provide justification in the Protection of Human Subjects attachment that no human subjects are involved. 5. Vertebrate Animals - If you answered “yes” to the question “are Vertebrate Animals Used?” On the R&R Other Project Information Form, you must address five points: a) a detailed description of animals’ species, strains, ages, sex, and numbers, b) justify the choice of species and numbers, c) veterinary care information, d) procedures for minimizing discomfort, pain, and injury, and e) method of euthanasia. Although no page limit applies, be succinct. 6. Multiple PD/PI Leadership Plan – must be included if designating multiple PD/PIs. Describe rationale for choosing a multiple PD/PI approach. Describe the governance and organization of the team, including procedures for resolving conflicts. If budget allocation is planned, delineate the distribution of resources. 7. Resource Sharing Plan: Include as a separate attachment, if not discussed in Approach section of Research Strategy. Data sharing plan: investigators seeking $500,000 USD or more in direct costs in any year are expected to include a brief 1-paragraph description of how final data will be shared, or explain why data sharing is not possible. Sharing Model Organisms: Regardless of the amount requested, all applications for the development of model organisms must include a specific plan for sharing or distributing organisms, or state why such sharing is restricted, or not possible. Genome Wide Association Studies (GWAS): Applicants seeking funding for a genome-wide association study are expected to provide a plan for submission of GWAS data to the NIH-designated GWAS data repository, or an explanation why submission is not possible. PHS 398 Cover Page Supplement 1. Project Director/Principle Investigator (PD/PI): First and last name are required fields. 2. Human Subject: Indicate whether it is a clinical trial. Phase III studies are done to study the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand) by comparing the intervention to other standard or experimental interventions as well as to monitor adverse effects, and to collect information that will allow the intervention to be used safely. 3. Disclosure Permission Statement: check “yes” or “no.” 4. Program Income: Indicate if program income is anticipated, if so enter the budget period, amount and sources in the columns. The total amount should match amount given in field 15. of SF 424 (R&R) form. If the application is funded, the Notice of Grant Award will provide specific instructions regarding the use of such income. 5. Human Embryonic Stem Cells: If “yes” is indicated, then either the “cannot be referenced box” Page 6 of 10 must be checked, or approved cell line entries must be included. An error will be generated stem cell lines given provided in chart are not listed on http://grants.nih.gov/stem_cells/registry/current.htm at the time of submission. If cell lines cannot be referenced, provide a strong justification for why an appropriate cell line is not available from the Registry at this time. The justification should be included as part of the Research Strategy or Program Plan as appropriate. 6. Inventions and Patents: only required for renewal applications. 7. Change of Investigator/Change of Institution: not generally applicable to a “new” application Research & Related Senior/Key Person Profile (Expanded) 1. Organization - name and complete address is required for PD/PI and all Sr/Key entries. 2. Credential – eRA Commons username is required for all PD/PIs. 3. Project Role – must be listed as PD/PI for first entry. 4. Biographical Sketch – attach for each person. Limited to 5 pages. Include each section (A - Personal Statement; B – Positions and Honors; C – Contributions to Science; D – Research Support or Scholastic Performance) A: Applicant may identify up to four peer reviewed publications that specifically highlight your experience and qualifications for this project. C: Include no more than 5 contributions to science with no more than 4 citations per contribution For each contribution, indicate the historical background that frames the scientific problem; the central finding(s); the influence of the finding(s) on the progress of science or the application of those finding(s) to health or technology; and your specific role in the described work Ensure that if you include the optional link to a full list of your published work in a site like My Bibliography that the URL is public, accessible without providing any login or personal information. D: List both selected ongoing and completed research projects for the past three years. Briefly indicate the overall goals of the projects and responsibilities. 5. Current & Pending Support – only provide if specifically requested in FOA. Research & Related Other Project Information 1. Human Subjects – If “yes” is indicated Include a “Protection of Human Subjects” in PHS 398 Research Plan attachments. “Inclusion of Women and Minorities,” “Targeted/Planned Enrollment Table,” and “Inclusion of Children” may also be required, if applicable. University of Calgary Human subject assurance number: 00000810 2. Vertebrate Animals – If “yes” is indicated, then include “Vertebrate Animals” in PHS 398 Research Plan attachments. University of Calgary Animal welfare assurance number: A5018-01 6. International collaborators – Indicate “yes.” 6.a. – Add “Canada” 6.b. – Add “Please refer to Foreign Justification statement” 7. Project Summary/Abstract - Typically 30 lines or less. System will give error if over 1 page. Should serve as a succinct description of the proposed work when separated from the application. State the application's broad, long-term objectives and specific aims, making reference to the health relatedness of the project (i.e., relevance to the mission of the agency). This section should be informative to other persons working in the same or related fields and insofar as possible understandable to a scientifically or technically literate reader. Page 7 of 10 8. Project Narrative - Typically 2-3 sentences. System will give error if over 1 page. Describe the relevance of this research to public health. Be succinct and use plain language that can be understood by a general, lay audience. 9. Bibliography & References Cited - Provide all publications cited throughout application. 10. Facilities & Other Resources – Shows capability of the organizational resources available for the effort proposed. Identify the facilities to be used (Laboratory, Animal, Computer, Office, Clinical and Other). If appropriate, indicate their capacities, pertinent capabilities, relative proximity and extent of availability to the project. Describe only those resources directly applicable to the proposed work. If applicable, describe any special facilities used for working with biohazards or other potentially dangerous substances. If there are multiple performance sites, describe the resources available at each site. For Early Stage Investigators (ESIs), describe institutional investment in the success of the investigator. See http://grants.nih.gov/grants/new_investigators/ 11. Equipment - List major items of equipment already available for this project and, if appropriate identify location and pertinent capabilities. 12. Other Attachments – Attach file named “Foreign Justification” to this section. Begin the section with a heading indicating “Foreign Justification.” Describe special resources or characteristics of the research project (e.g., human subjects, animals, disease, equipment, and techniques), whether similar research is being done in the United States and whether there is a need for additional research in this area. Can highlight here that as F&A rate is only 8%, doing research in Canada provides considerable savings. Project/Performance Site Location(s) Project/Performance Site Location Organization Name: The Governors of the University of Calgary DUNS Number: 2076639150000 Address: 2500 University Drive NW, Calgary, Alberta, CAN: CANADA, T2N 1N4 Congressional District: 00-000 If sub-sites are involved on application, include their addresses below Research & Related Budget R &R Budget – To add this budget, check the “Research & Related” box in the Optional forms section on page 1 of the application package. Foreign institutions are not eligible to use the “PHS 398 Modular Budget” Additional Budget Periods must be added to the application by checking the “Add Period” button on the 3 rd page of this attachment. This process must be repeated for all subsequent periods. DUNS Number: 2076639150000 Organization Name: The Governors of the University of Calgary Budget Type: check “Project” Ensure Budget Periods match those given on SF 424 (R&R). A detailed budget must be completed for each year of support requested. Budget periods are usually 12 months. While the dollar fields allow cents to be entered, all dollar fields should be presented in whole numbers. Round to the nearest whole number. All requests for Funding and Payment, including the budget contained in the application, must be stated in U.S. Dollars. Ensure that the total project period does not exceed that given on “Section II. Award Information” of the FOA. Ensure that the direct costs for any single year and the cumulative budget do not exceed the max. request Page 8 of 10 noted in “Section II. Award Information” of the FOA. Revision (Supplemental) Application: show only those items for which additional funds are requested. A. Senior/Key Person This section should include the names of all senior/key persons at the applicant organization who are involved on the project in a particular budget year. Include all collaborating investigators, and other individuals meeting the senior/key person definition if they are from the applicant organization. Details of collaborators at other institutions will be provided in the Subaward budget for each subaward/consortium organization. Personnel listed as Other Significant Contributors who are not committing any specific measurable effort to the project should not be included in the Personnel section of the budget since no associated salary and/or fringe benefits should be requested for their contribution. Base Salary: An applicant organization may choose to leave this blank; however, NIH staff will request this information prior to award for personnel requesting salary. If requesting salary, ensure that this amount does not exceed the NIH Salary cap, set at approx. $180,000. A salary cap calculator is available online. Calendar Months: Use either calendar months OR a combination of academic and summer months to indicate percent of effort. Q&A and a conversion calculator are available at: http://grants.nih.gov/grants/policy/person_months_faqs.htm. Project Roles - Principle Investigators role must be PD/PI, not PI. PI will generate an error which will prevent submission to NIH. Multiple PI applications: Co-PD/PI not an applicable role for NIH applications. List Co-PIs as PD/PI. B. Other Personnel Calendar Months: Use either calendar months OR a combination of academic and summer months to indicate percent of effort. C. Equipment Description Equipment is defined as an item of property that has an acquisition cost of $5,000 or more, and an expected service life of more than one year. If a short service life (< 1 year), even if it costs more than $5,000, can instead be listed as “supplies”. No F&A charged on Equipment over $5,000. Do not include in indirect cost base in Section H. Justify the need to buy instead of rent. D. Travel Travel to Canada, the US and Mexico all considered domestic. F. Other Direct Costs Materials and supplies: categories of less than $1,000 do not need to be itemized. Subawards/Consortium/Contractual Costs: This line item should include both direct and indirect costs for all subaward/consortium organizations. NIH policy provides for exclusion of consortium/contractual F&A costs when determining if an applicant is in compliance with a direct cost limitation. See the Supplemental Instructions, Part III, Section 1.1 for additional information. Equipment or facility Rental/User Fees: Rental costs are allowable to the extent that the rates are reasonable at the time of the decision to lease. Alterations and Renovations: Costs for any A&R were previously unallowable on applications from foreign institutions. However, an HHS policy change now allows for minor A&R (≤$500,000) on these applications. H. Indirect Costs Indirect cost type: F&A foreign rate Indirect cost rate: 8 Indirect cost base: Total direct costs, excluding equipment (over $5,000 USD) K. Budget Justification Budget justification attached only to “Budget Period 1,” but should describe all project periods. Consortium application: Check “R & R Subaward Budget Attachment(s)” box in the Optional forms Page 9 of 10 section on page 1 of the application package. Budget Type: check “Subaward/Consortium” Ensure that the Budget Period dates match for the Project and Subaward budgets. Budget justification should be included for consortium site. C. Submitting the Application to NIH Complete the internal University of Calgary Research Funding Application Approvals form, with signatures of PI, Department Head, and Dean or Associate Dean (Research) and email the form and NIH application PDF to nihgrant@ucalgary.ca Once RSO receives both the application PDF and the internal approvals form, your application will be placed in a queue for review and approval. If submitted 2 weeks prior to the agency deadline, it will receive a detailed review. Applications submitted less than 2 weeks prior to the agency deadline will receive a basic review only, checking for errors that will prevent submission to Grants.gov, as well as eligibility, U of C commitments, and risk. The final deadline for RSO to receive applications is 4 business days prior to the agency deadline. Once Research Services has approved and submitted your application to NIH, an email will be sent to the PI with the Grants.gov tracking number, once processed through the system. If any errors or warning are detected during submission to NIH, an email with be sent to RSO and the PI. Errors will prevent submission and must be corrected, whereas warnings will not prevent submission. As it can take time for errors or warning to be detected, early submission to NIH is highly recommended. REVIEW CRITERIA Initial peer review of NIH grant applications is coordinated by the Center for Scientific Review (CSR) or another NIH IC. The initial peer review is an assessment of scientific and technical merit, conducted by a Scientific Review Group (SRG) composed primarily of non-federal scientists who have relevant expertise. The outcome of the initial review is provided to the PI in a NIH Summary Statement, which contains written critiques and criterion scores from at least 3 reviewers, the final score and meeting rooster. It may also contain a summary of the discussion at the SRG meeting. The second level of review, known as Council review, is conducted by IC National Advisory Councils or Boards, composed of both scientific members and public representatives. Reviewers provide an Overall Impact score to reflect “the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved.” All NIH applications are rated according to the standard review criteria. The NIH uses a nine-point scoring system (1 = highest impact, 9 = lowest impact) for all applications. 1. Significance 2. Does the project address an important problem or a critical barrier to progress in the field? If the aims are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? Investigator(s) Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project? Page 10 of 10 3. Innovation Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed? 4. Approach 5. Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from risks, and 2) the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (exclusion) of children, justified in terms of the scientific goals and research strategy proposed? Environment Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?